ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1409

Clinical Features at Disease Onset of Different Subsets of Large-vessel-giant Cell Arteritis in a Monocentric Cohort of 100 Patients

Francesca Regola1, Giovanni Bosio2, Laura Andreoli3, Franco Franceschini1 and Paola Toniati1, 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, 2Nuclear Medicine Unit, ASST Spedali Civili of Brescia, Brescia, Italy, 3University of Brescia, Brescia, Italy

Meeting: ACR Convergence 2021

Keywords: giant cell arteritis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Giant Cell Arteritis & Polymyalgia Rheumatica (1391–1419)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Giant Cell Arteritis (GCA) is the most frequent systemic vasculitis in patients older than 50 years involving medium-sized and large arteries. Inflammation of the extracranial branches of the carotid artery gives rise to the classic symptoms of GCA. However, GCA involves also the aorta and its major branches in almost two-thirds of patients (1,2). Large vessel involvement leads to a different atypical clinical picture which can be challenging to diagnose (3). More information on clinical presentation and vessel involvement in large-vessel GCA are needed to better diagnose it. The aim of this study is to analyze a large cohort of GCA comparing patients with large-vessel involvement to patients with classical cranial disease.

Methods: 100 consecutive patients with a clinical diagnosis of GCA were enrolled in this retrospective study. All patients were older than 50 years of age, met the ACR criteria for GCA (4) or had a positive temporal artery biopsy or evidence of large vessel vasculitis at FDG-PET/CT scan.

Results: Based on vascular involvement, patients were classified into three group: 61 patients with only cranial arteritis (C-GCA), 16 patients with only extracranial large vessel vasculitis (LV-GCA) and 23 patients with both cranial and large vessel involvement (LV-C-GCA).

Compared to C-GCA, patients with large vessel involvement (LV-GCA and LV-C-GCA) were younger and more frequently women, and the difference was further significant for patients with isolated LV-GCA. Patients with isolated LV-GCA had also the longer duration of symptoms at GCA diagnosis [LV-GCA 20(16-82) vs LV-C-GCA 12(4-16) vs C-GCA 4(3-12) weeks; p< 0.001]. Systemic symptoms, as fever and fatigue, were associated with large vessel involvement, both in LV-GCA and LV-C-GCA groups. Polymyalgia rheumatica was equally reported in all three groups and no significant differences were found in inflammatory markers levels according to vessel involvement. In patients with large vessels involvement (LV-GCA and LV-C-GCA) thoracic aorta, subclavian arteries and abdominal aorta were the most frequently involved arteries.

Conclusion: GCA is not a single entity but includes several patterns of disease. Female gender, younger age and systemic symptoms are associated with large vessel involvement, regardless the presence or absence of cranial symptoms. The different clinical manifestations of large vessel GCA lead to a longer time to diagnosis if compared to C-GCA. For these reasons, in patients with the aforementioned characteristics, a large vessel involvement should be considered in order to reduce the time to diagnosis.

1: De Boysson H, et al. Clin Exp Rheumatol 2019; 2: Prieto-González S, et al. Ann Rheum Dis 2012; 3: Muratore F, et al. Rheumatol 2015; 4: Hunder GG, et al. Arthritis Rheum 1990


Disclosures: F. Regola, None; G. Bosio, None; L. Andreoli, None; F. Franceschini, None; P. Toniati, None.

To cite this abstract in AMA style:

Regola F, Bosio G, Andreoli L, Franceschini F, Toniati P. Clinical Features at Disease Onset of Different Subsets of Large-vessel-giant Cell Arteritis in a Monocentric Cohort of 100 Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/clinical-features-at-disease-onset-of-different-subsets-of-large-vessel-giant-cell-arteritis-in-a-monocentric-cohort-of-100-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-features-at-disease-onset-of-different-subsets-of-large-vessel-giant-cell-arteritis-in-a-monocentric-cohort-of-100-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology